Page last updated: 2024-12-07
3-methoxybenzanthrone
3-Methoxybenzanthrone is a synthetic organic compound that has attracted attention due to its potential applications in various fields, including organic electronics, fluorescence imaging, and as a precursor for other valuable compounds. It exhibits strong fluorescence properties, making it suitable for use in fluorescent probes and sensors. The compound is typically synthesized through a multi-step process involving Friedel-Crafts acylation and subsequent cyclization reactions. Research efforts focus on understanding its photophysical properties, exploring its potential as an organic semiconductor material, and investigating its interactions with biological systems.'
Cross-References
ID Source | ID |
PubMed CID | 77267 |
SCHEMBL ID | 3380389 |
MeSH ID | M0082373 |
Synonyms (33)
Synonym |
7h-benz[de]anthracen-7-one, 3-methoxy- |
e1tv38vz4c , |
unii-e1tv38vz4c |
EU-0066739 |
c.i. 58900 |
einecs 222-992-6 |
7h-benz(de)anthracen-7-one, 3-methoxy- |
3-methoxybenzanthrone |
3-methoxy-7h-benz(de)anthracen-7-one |
duranol brilliant yellow g |
acetate yellow 6g |
c.i. disperse yellow 13 |
disperse yellow 13 |
celliton brilliant yellow 8g |
brn 2055284 |
duranol brilliant yellow 6g |
disperse yellow 6z |
AKOS000592561 |
3688-79-7 |
SCHEMBL3380389 |
3-methoxybenzo[b]phenalen-7-one |
CCG-103163 |
3-methoxy-7h-benz[de]anthracen-7-one |
STL363244 |
3-methoxy-7h-benzo[de]anthracen-7-one |
DTXSID7063136 |
3-methoxy-7-oxo-7h-benz(de)anthracene |
ci 58900 |
ci disperse yellow 13 |
sr-01000389302 |
SR-01000389302-1 |
BGQDCDRDPCVLJE-UHFFFAOYSA-N |
Q27276759 |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 8 (72.73) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.45
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.45 (24.57) | Research Supply Index | 2.71 (2.92) | Research Growth Index | 4.16 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |